Recent developments in the management of severe asthma
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Recent developments in the management of severe asthma. / Meteran, Howraman; Tønnesen, Louise Lindhardt; Sivapalan, Pradeesh; Ingebrigtsen, Truls Sylvan; Jensen, Jens Ulrik Stæhr.
In: Breathe, Vol. 18, No. 1, 210178, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Recent developments in the management of severe asthma
AU - Meteran, Howraman
AU - Tønnesen, Louise Lindhardt
AU - Sivapalan, Pradeesh
AU - Ingebrigtsen, Truls Sylvan
AU - Jensen, Jens Ulrik Stæhr
PY - 2022
Y1 - 2022
N2 - Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation.
AB - Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation.
U2 - 10.1183/20734735.0178-2021
DO - 10.1183/20734735.0178-2021
M3 - Journal article
C2 - 36338257
AN - SCOPUS:85130756860
VL - 18
JO - Breathe
JF - Breathe
SN - 1810-6838
IS - 1
M1 - 210178
ER -
ID: 327686931